logo
Living with celiac disease: When a single crumb can hurt you

Living with celiac disease: When a single crumb can hurt you

CBC02-04-2025
When Ana Amezcua's family moved from Mexico to Canada in 2019, she never anticipated what would soon unfold with her daughter René, who was just five years old.
"We noticed that within a week she started being always sick, like with a lot of fever, she couldn't stand up out of the bed, she lost a lot of weight," said Amezcua, who lives in Moncton.
"We were going to the ER, but apparently she had nothing."
That was when she remembered a TV show she had watched that talked about celiac disease and then everything started to make sense. Since moving to Canada, the family's diet included more wheat products, which would trigger someone who has celiac.
Celiac disease is an autoimmune condition that primarily affects the small intestine when the person ingests gluten, which is found in wheat, barley and rye.
Symptoms differ from person to person, according to the Celiac Disease Foundation. Some common symptoms include abdominal pain, cognitive impairment, migraines, fatigue, skin rash, joint pain and vomiting.
According to the foundation, celiac can also lead to long-term health conditions, such as heart disease, liver failure, small bowel cancers and neurological symptoms.
Amezcua began advocating for her daughter to get tested for celiac, and when she got the positive result, everything changed.
Eating at home was safe. Amezcua, who is a certified chef, adapted her cooking to René's needs.
But when she was anywhere else, there was always the fear that, even if a food appeared to be free of gluten, it could still be cross-contaminated, which could still cause extreme sickness.
She said restaurants will often say they are celiac safe, but her daughter could still get sick if her food shares a countertop or frying pan with an item that contains gluten.
Aislynn Slupsky, also a Moncton resident, has experienced similar challenges since her daughter, Kalina, was diagnosed at the age of four.
She said her family had to get entirely new pots, pans, a toaster and even dedicated cutlery to ensure Kalina didn't get sick.
WATCH | 'It didn't even cross our mind':
Even Play-Doh is off limits for kids with celiac disease
1 day ago
Duration 0:46
And when Kalina started school last year, that came with its own set of challenges.
Slupsky found out that Play-Doh contains wheat and her daughter wouldn't be able to participate in the class activity, unless she found an alternative, because it was too risky if Kalina were to touch her mouth after playing.
It was something that hadn't crossed her mind until she was confronted with the situation.
While most people understand that people with celiac can't have bread products, many non-bread products also contain gluten, such as soy sauce, some types of vinegar, certain taco seasonings, some blue or cottage cheeses and many types of ice cream.
Slupsky has had to tell Kalina not to take food from other people, but it's not always easy to explain why some kids can have things and she can't.
"Some adults don't like to be told what to do, so imagine a five-year-old," she said.
"She hasn't really known any difference, because, you know, she was four when it all started, but you can definitely see the frustration in her whenever friends get to participate and she doesn't."
The isolation in school settings can be one of the hardest parts of having the disease — as was the case for Amber MacDonald when she was diagnosed with celiac in Grade 11.
The 23-year-old Miramichi resident said that she often felt left out in school, as if she were a burden on her school and even society as a whole.
After her diagnosis, MacDonald realized that grabbing a bite at the cafeteria or sharing a treat with her classmates was something she took for granted.
She remembers a day that her school had a pancake breakfast as a way to promote school spirit.
"To sit in a cafeteria surrounded by the entire school eating this pancake breakfast and being able to share in this moment altogether, and being one of the only ones sitting there without … it was just kind of an uncomfortable feeling."
MacDonald said she hopes that the knowledge of celiac disease continues to grow, so people realize that being gluten-free isn't just a fad for those who suffer from celiac and they aren't being dramatic when it comes to cross-contamination.
"I will live with this for the rest of my life, and the only way for me to live a life that is not in excruciating pain is to eat an entirely gluten-free diet," she said.
"Having that one crumb or eating at that one restaurant that doesn't have great rules and regulations for cross-contamination would genuinely cause me weeks and weeks and weeks of pain and potentially long-term damage that might cause serious health issues down the road."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GM strikes deal with Noveon Magnetics for supply of rare earth magnets
GM strikes deal with Noveon Magnetics for supply of rare earth magnets

Yahoo

time7 minutes ago

  • Yahoo

GM strikes deal with Noveon Magnetics for supply of rare earth magnets

General Motors (GM) has inked a multi-year agreement with Noveon Magnetics, a US-based company, for the supply of rare earth magnets essential for various vehicle components and for its full-size trucks and SUVs. The partnership between GM and Noveon began with immediate production, and the first batch of magnets was delivered last month. This latest agreement, along with GM's previous contracts with MP Materials Corp and E-Vac Magnetics, a unit of Germany's Vacuumschmelze based in the US, will enable GM to source the majority of its rare-earth magnets domestically. This contract is a significant step in setting up a reliable supply chain within the US, especially considering the recent export controls imposed by China on rare-earth magnet production as a countermeasure to US tariff threats. Noveon is said to be the sole operational producer of sintered NdFeB rare earth magnets in the country. It provides a vertically integrated, wholly domestic solution for the critical supply of these magnets. The company said its EcoFlux magnets are designed for 'greater resource efficiency', incorporating the use of recycled materials. Noveon's magnets are integral to various critical applications, including electric vehicles (EVs). Noveon Magnetics CEO Scott Dunn said: 'We're proud to be delivering critical rare earth magnets in support of some of America's most iconic vehicles. 'This agreement is a testament to what American manufacturers like GM and Noveon can do to develop supply chains and partnerships right here in the US.' GM global chief procurement officer Jeff Morrison said: 'Working with domestic manufacturers like Noveon allows us to increase the resiliency of our supply chain while supporting American jobs and strengthening our industry and economic security.' GM's collaboration with MP Materials started in 2021, aimed at establishing a US supply chain for these magnets. GM reported a significant decline in profits, with a $1.1bn impact in the second quarter (Q2) attributed to the repercussions of trade tariffs. The company's net income fell to $1.9bn, a reduction of over a third from the previous year. This occurred even though global unit sales saw an increase from 1.43 million in Q2 2024 to 1.54 million in Q2 2025. "GM strikes deal with Noveon Magnetics for supply of rare earth magnets" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tim Hortons drives second quarter growth at parent Restaurant Brands
Tim Hortons drives second quarter growth at parent Restaurant Brands

Yahoo

time7 minutes ago

  • Yahoo

Tim Hortons drives second quarter growth at parent Restaurant Brands

Restaurant Brands International Inc. reported improved sales led by the Tim Hortons brand and its international businesses in the second quarter, as the industry sees consumer confidence start to bounce back. The company recorded total revenues of US$2.4 billion in the quarter ended June 30, up from US$2.08 billion in the prior year and above consensus of US$2.3 billion. 'While consumer environment remains dynamic, we've seen encouraging signs of improvement across many of our largest businesses,' chief executive Josh Kobza said during the company's earnings call on Thursday. RBI reported consolidated system-wide sales growth of 5.3 per cent, up from five per cent a year ago. System-wide sales were US$11.85 billion, up from US$11.25 billion. Second quarter adjusted operating income of US$668 million was in line with consensus of US$664 million and up from the previous year's US$632 million. Tim Hortons and International segments together accounted for nearly 70 per cent of RBI's adjusted operating income, doing most of the heavy lifting in the quarter. The iconic Canadian brand, which accounts for 40 per cent of the company's revenue, had total revenue of US$1.08 billion, a slight increase from US$1.03 billion in 2024. Tim Hortons reported adjusted operating income of US$278 million, up from US$269 million. 'We also saw solid improvement across the rest of the business and I feel confident in our ability to build on that momentum in the second half of the year,' Kobza said. RBI's overall comparable sales grew to 2.4 per cent from 1.9 per cent in the second quarter. This includes comparable sales growing to 3.4 per cent at Tim Hortons and 3.6 per cent at Tim Hortons Canada, a slight slowdown from the previous year's 4.6 per cent and 4.9 per cent growth, respectively. Kobza said this is Tim Horton's 17th consecutive quarter of positive comparable sales in Canada. He said the brand is making progress on development and remains on track to return to modest net restaurant growth in Canada in 2025. 'This quarter marked a clear return to consistent performance we've come to expect from the Tim's brand,' he said. Chief financial officer Sami Siddiqui said the company is seeing some normalization in coffee prices following a period of historic highs, which he said is welcome news for the Tim Hortons business, where coffee accounts for around 15 per cent of the commodity basket. Siddiqui said they're pleased to see improvements from Q1 to Q2 in the Canada trends. Tim Horton's parent misses estimates as consumer confidence dips Tim Hortons parent doubles earnings on stronger sales He said Tim Hortons has been 'doing really well consistently,' but has also seen some sequential improvement in consumer confidence indices throughout the second quarter and into the third quarter. • Email: dpaglinawan@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Eli Lilly's Mounjaro Shows Cardiovascular Benefits in Head-to-Head Trial
Eli Lilly's Mounjaro Shows Cardiovascular Benefits in Head-to-Head Trial

Yahoo

time7 minutes ago

  • Yahoo

Eli Lilly's Mounjaro Shows Cardiovascular Benefits in Head-to-Head Trial

Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, Eli Lilly announced the topline results from its SURPASS-CVOT trial/NCT04255433, which is a phase III study that investigated the cardiovascular benefits of its dual-agonist drug Mounjaro (tirzepatide). The ~5-year trial involved 13,299 patients with type 2 diabetes and established atherosclerotic cardiovascular disease, comparing once-weekly Mounjaro against Trulicity (dulaglutide), which is another GLP-1 RA from Eli Lilly. The study achieved its primary endpoint by demonstrating Mounjaro's noninferiority to Trulicity in reducing the 3 major adverse cardiovascular events/MACE-3, which include cardiovascular death, heart attack, or stroke. Overall, Mounjaro reduced the MACE-3 by 8% compared to Trulicity. Analysts from William Blair and Citi expressed disappointment that the trial did not show superiority over Trulicity. A close-up of a staff member counting pills in a pharmaceutical warehouse. Mounjaro reduced MACE-3 by an estimated 28% and all-cause mortality by 39% when compared to a placebo. Additionally, Mounjaro led to greater improvements in A1C, weight, and cardiovascular biomarkers. A significant finding was a 16% lower rate of all-cause mortality compared to Trulicity, as well as greater kidney protection Eli Lilly and Company (NYSE:LLY) discovers, develops, and markets human pharmaceuticals in the US, Europe, China, Japan, and internationally. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store